Afinitor (Everolimus) Combo For Breast Cancer Approved By FDA
The FDA has approved Afinitor (everolimus) in combination with Aromasin (exemestane) for the treatment of some postmenopausal females with advanced hormone-receptor positive, HER2-negative breast cancer...